Dendritic cells transduced with lentiviral vectors expressing vip differentiate into vip-secreting tolerogenic-like DCs

Molecular Therapy

Volumn 18, Issue 5, 2010, Pages 1035-1045

  Toscano, Miguel G ^a   Delgado, Mario ^b   Kong, Weimin ^a   Martin, Francisco ^c   Skarica, Mario ^a   Ganea, Doina ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LENTIVIRUS VECTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CECUM; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EXPERIMENTAL LIGATION; FEMALE; GENETIC ENGINEERING; GENETIC TRANSDUCTION; INFLAMMATORY DISEASE; INOCULATION; MOUSE; NONHUMAN; PERITONEAL FLUID; PHENOTYPE; PUNCTURE; SEPSIS; SPINAL CORD; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC VECTORS; LENTIVIRUS; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

MUS;

EID: 77952012067     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.293     Document Type: Article

References (47)

1. Wolfraim, LA (2006). Treating autoimmune diseases through restoration of antigen-specific immune tolerance. Arch Immunol Ther Exp (Warsz) 54:1-13.
2. Roth, JC, Curiel, DT and Pereboeva, L (2008). Cell vehicle targeting strategies. Gene Ther 15:716-729.
3. Steinman, RM (1991). The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296.
4. Banchereau, J and Steinman, RM (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
5. Steptoe, RJ and Thomson, AW (1996). Dendritic cells and tolerance induction. Clin Exp Immunol 105:397-402.
6. Wakkach, A, Fournier, N, Brun, V, Breittmayer, JP, Cottrez, F and Groux, H (2003). Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605-617.
7. Mahnke, K, Schmitt, E, Bonifaz, L, Enk, AH and Jonuleit, H (2002). Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80:477-483.
8. Steinman, RM, Hawiger, D and Nussenzweig, MC (2003). Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711.
9. Takayama, T, Nishioka, Y, Lu, L, Lotze, MT, Tahara, H and Thomson, AW (1998). Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66:1567-1574.
10. Lee, WC, Zhong, C, Qian, S, Wan, Y, Gauldie, J, Mi, Z et al. (1998). Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β. Transplantation 66:1810-1817.
11. Morita, Y, Yang, J, Gupta, R, Shimizu, K, Shelden, EA, Endres, J et al. (2001). Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 107:1275-1284.
12. Delgado, M, Pozo, D and Ganea, D (2004). The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56:249-290.
13. Delgado, M, Abad, C, Martinez, C, Leceta, J and Gomariz, RP (2001). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7:563-568.
14. Abad, C, Martinez, C, Juarranz, MG, Arranz, A, Leceta, J, Delgado, M et al. (2003). Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 124:961-971.
15. Keino, H, Kezuka, T, Takeuchi, M, Yamakawa, N, Hattori, T and Usui, M (2004). Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. Arch Ophthalmol 122:1179-1184.
16. Herrera, JL, Fernández-Montesinos, R, González-Rey, E, Delgado, M and Pozo, D (2006). Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice. Ann N Y Acad Sci 1070:337-341.
17. Chorny, A, Gonzalez-Rey, E, Fernandez-Martin, A, Pozo, D, Ganea, D and Delgado, M (2005). Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc Natl Acad Sci USA 102:13562-13567.
18. Delgado, M, Gonzalez-Rey, E and Ganea, D (2005). The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J Immunol 175:7311-7324. (Pubitemid 41713427)
19. Pozo, D, Anderson, P and Gonzalez-Rey, E (2009). Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. J Immunol 183:4346-4359.
20. Fraccaroli, L, Alfieri, J, Larocca, L, Calafat, M, Roca, V, Lombardi, E et al. (2009). VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells. Br J Pharmacol 156:116-126.
21. Sherwood, NM, Krueckl, SL and McRory, JE (2000). The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21:619-670.
22. Miyata, A, Arimura, A, Dahl, RR, Minamino, N, Uehara, A, Jiang, L et al. (1989). Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574.
23. Piemonti, L, Monti, P, Allavena, P, Sironi, M, Soldini, L, Leone, BE et al. (1999). Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473-6481.
24. Penna, G and Adorini, L (2000). 1α, 25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-2411.
25. Ilarregui, JM, Croci, DO, Bianco, GA, Toscano, MA, Salatino, M, Vermeulen, ME et al. (2009). Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 10:981-991.
26. Paul, S, Sun, M, Mody, R, Tewary, HK, Stemmer, P, Massey, RJ et al. (1992). Peptidolytic monoclonal antibody elicited by a neuropeptide. J Biol Chem 267:13142-13145.
27. Dieu, MC, Vanbervliet, B, Vicari, A, Bridon, JM, Oldham, E, Aït-Yahia, S et al. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386.
28. McFarland, HF and Martin, R (2007). Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8:913-919.
29. Liu, Z, Xu, X, Hsu, HC, Tousson, A, Yang, PA, Wu, Q et al. (2003). CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332-1341.
30. Sarkar, S, Tesmer, LA, Hindnavis, V, Endres, JL and Fox, DA (2007). Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4. Arthritis Rheum 56:89-100.
31. Morelli, AE, Larregina, AT, Ganster, RW, Zahorchak, AF, Plowey, JM, Takayama, T et al. (2000). Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol 74:9617-9628.
32. Kaplan, JM, Yu, Q, Piraino, ST, Pennington, SE, Shankara, S, Woodworth, LA et al. (1999). Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J Immunol 163:699-707.
33. Roe, T, Reynolds, TC, Yu, G and Brown, PO (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12:2099-2108.
34. Dyall, J, Latouche, JB, Schnell, S and Sadelain, M (2001). Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 97:114-121.
35. Zhao, Y, Keating, K and Thorpe, R (2007). Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy. Toxicol Appl Pharmacol 225:189-197.
36. Breckpot, K, Dullaers, M, Bonehill, A, van Meirvenne, S, Heirman, C, de Greef, C et al. (2003). Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gene Med 5:654-667.
37. He, Y, Zhang, J, Mi, Z, Robbins, P and Falo, LD Jr (2005). Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol 174:3808-3817.
38. Henry, E, Desmet, CJ, Garzé, V, Fiévez, L, Bedoret, D, Heirman, C et al. (2008). Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J Immunol 181:7230-7242.
39. Delgado, M, Toscano, MG, Benabdellah, K, Cobo, M, O'Valle, F, Gonzalez-Rey, E et al. (2008). In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Arthritis Rheum 58:1026-1037.
40. Noser, JA, Towers, GJ, Sakuma, R, Dumont, JM, Collins, MK and Ikeda, Y (2006). Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. J Virol 80:7769-7774.
41. Verbovetski, I, Bychkov, H, Trahtemberg, U, Shapira, I, Hareuveni, M, Ben-Tal, O et al. (2002). Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196:1553-1561.
42. Morelli, AE and Thomson, AW (2007). Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7:610-621.
43. Chan, J, Ban, EJ, Chun, KH, Wang, S, Bäckström, BT, Bernard, CC et al. (2008). Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 181:7571-7580.
44. Makar, TK, Trisler, D, Bever, CT, Goolsby, JE, Sura, KT, Balasubramanian, S et al. (2008). Stem cell based delivery of IFN-β reduces relapses in experimental autoimmune encephalomyelitis. J Neuroimmunol 196:67-81.
45. Zufferey, R, Dull, T, Mandel, RJ, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
46. Toscano, MG, Frecha, C, Ortega, C, Santamaría, M, Martín, F and Molina, IJ (2004). Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies. Gene Ther 11:956-961.
47. Jing, H, Yen, JH and Ganea, D (2004). A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. J Biol Chem 279:55176-55186.